<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)
and (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
(Amendment No.1)/1/
NITINOL MEDICAL TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.001 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
65476T104
----------------
(CUSIP Number)
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6
<PAGE>
CUSIP No. 65476T104 13G Page 2 of 6 Pages
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITITS ONLY)
C. Leonard Gordon
ss#______________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5 SOLE VOTING POWER
268,271 shares which Mr. Gordon has the right to acquire within
60 days after December 31, 1997
6 SHARED VOTING POWER
468,304 shares
7 SOLE DISPOSITIVE POWER
268,271 shares which Mr. Gordon has the right to acquire within
60 days after December 31, 1997
8 SHARED DISPOSITIVE POWER
468,304 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
736,575 shares (includes 268,271 shares which Mr. Gordon has the right to
acquire within 60 days after December 31, 1997)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not Applicable
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.3%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 65476T104
- -------------------
Item 1(a) Name of Issuer:
- --------- --------------
Nitinol Medical Technologies, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
- --------- ----------------------------------------------
27 Wormwood Street
Boston, MA 02210
Item 2(a) Name of Person Filing:
- --------- ---------------------
C. Leonard Gordon
Item 2(b) Address of Principal Business Office or, if none, Residence:
- --------- -----------------------------------------------------------
Immunotherapy, Inc.
360 Lexington Avenue
New York, New York 10017
Item 2(c) Citizenship:
- --------- -----------
United States of America
Item 2(d) Title of Class of Securities:
- --------- ----------------------------
Common Stock, $.001 par value per share.
Item 2(e) CUSIP Number:
- --------- ------------
65476T104
Item 3 Description of Person Filing:
- ------ ----------------------------
Not applicable
Item 4 Ownership:
- ------ ---------
(a) Amount Beneficially Owned:
-------------------------
736,575 shares (includes 268,271 shares which Mr. Gordon has
the right to acquire within 60 days after December 31, 1997)
Page 3 of 6
<PAGE>
CUSIP No. 65476T104
- -------------------
(b) Percent of Class:
----------------
7.3%
(c) Number of shares as to which person has:
----------------------------------------
(1) sole power to vote or to direct the vote:
268,271 shares which Mr. Gordon has the right
to acquire within 60 days after December 31, 1997
(ii) shared power to vote or to direct the vote:
468,304 shares
(iii) sole power to dispose or to direct the disposition
of:
268,271 shares which Mr. Gordon has the right to
acquire within 60 days after December 31, 1997
(iv) shared power to dispose or to direct the
disposition of:
468,304 shares
Item 5 Ownership of Five Percent of Less of a Class:
- ------ --------------------------------------------
Not applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
- ------ ---------------------------------------------------------------
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which
- ----- ---------------------------------------------------------
Acquired the Security Being Reported on by the Parent Holding
-------------------------------------------------------------
Company:
-------
Not applicable.
Item 8 Identification and Classification of Members of the Group:
- ------ ---------------------------------------------------------
Not applicable.
Page 4 of 6
<PAGE>
CUSIP No. 65476T104
- -------------------
Item 9 Notice of Dissolution of Group:
- ------ -------------------------------
Not applicable.
Item 10 Certification:
- ------- -------------
Not applicable.
Page 5 of 6
<PAGE>
CUSIP No. 65476T104
- -------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 5, 1998 /s/ C. Leonard Gordon
------------------------
C.Leonard Gordon
Page 6 of 6
